Table 2.
Immunohistochemistry patient data
| Protein Expression | No of patients (%) | p-value | |
|---|---|---|---|
| ITP | IP | ||
| ERCC 1 | |||
| High | 11 (50) | 9 (42.9) | 0.906 |
| Moderate | 5 (22.7) | 7 (33.3) | |
| Low | 2 (9.1) | 2 (9.5) | |
| None | 4 (18.2) | 3 (14.3) | |
| COX 2 | |||
| High | 7 (31.8) | 5 (23.8) | 0.342 |
| Moderate | 5 (22.7) | 7 (33.3) | |
| Low | 4 (18.2) | 7 (33.3) | |
| None | 6 (27.3) | 2 (9.5) | |
| III beta tubulin | |||
| High | 11 (50) | 9 (42.9) | 0.425 |
| Moderate | 8 (36.4) | 5 (23.8) | |
| Low | 3 (13.6) | 6 (28.6) | |
| None | 0 (0) | 1 (4.8) | |
| CD4 | |||
| High | 0 (0) | 0 (0) | 0.768 |
| Moderate | 3 (13.6) | 4 (19) | |
| Low | 6 (27.3) | 7 (33.3) | |
| None | 13 (59.1) | 10 (47.6) | |
| CD8 | |||
| High | 1(4.5) | 0 (0) | 0.226 |
| Moderate | 3 (13.6) | 3 (14.3) | |
| Low | 3 (13.6) | 8 (38.1) | |
| None | 15 (68.2) | 10 (47.6) | |
ITP Ifosfamide Paclitaxel Cisplatin, IP Ifosfamide Cisplatin